Clinical Trial

The Registry Study of Genetic Alterations of Oropharyngeal Cancer in Taiwan

Recruiting
View on ClinicalTrials.gov →
Summary
We will use the next-generation sequencing (NGS) technology to identify genomic alterations of Taiwanese HPV positive and negative oropharyngeal squamous cell carcinoma (OPSCC) for novel biomarker development and the study design of potential clinical trials or translational research.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2022-08-29; most recent amendment 2026-07-01.
Status change: Not Yet Recruiting → Recruiting 2022-11-18
Trial Details
NCT Number NCT05522881
Lead Sponsor National Health Research Institutes, Taiwan
Collaborators: National Taiwan University Hospital, Taipei Veterans General Hospital, Taiwan, China Medical University Hospital, Taichung Veterans General Hospital, National Cheng-Kung University Hospital, Kaohsiung Veterans General Hospital., Kaohsiung Medical University Chung-Ho Memorial Hospital
Conditions Oropharyngeal Squamous Cell Carcinoma
Enrollment 410 participants
Start Date 2022-11-25
Primary Completion 2029-12 (estimated)
Study Completion 2029-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-02